Procedures for 18-month or exit visit for all participants
Examination of HIV care documentation
ADVERSE EVENTS
Follow-up visits at month 18 or exit will take place in person at the mobile van, home, or clinic, by participant choice. At the follow-up visits, counselors will answer questions and provide support for HIV care. Participants will complete a questionnaire on their experience accessing care, including barriers to care, linkage to care, uptake of ART, adherence, adverse events, reasons for loss to follow-up, CD4 and viral load testing, social harms, risk behavior, cost of engaging in care, HIV clinical care including co-infections, and knowledge of HIV treatment and prevention. Examination of HIV care documentation (e.g., registration card from HIV care clinic) and recording of medications (e.g., HIV care medications and ART) will take place. If feasible, chart extraction will be conducted to record engagement in HIV care and lab monitoring for all participants. A maximum of 11 mL of blood (2 teaspoons) will be collected for viral load and creatinine testing. The specimens will be disposed of after testing has taken place. HIV viral load testing will use the gold standard PCR viral load test or the validated alternate approach. The viral load result will be made available to the participant, with counseling to help with the interpretation of the result.